- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Antibiotic Pipeline Coordinators
Journal of Law, Medicine and Ethics 46 (s1):25-31 (2018)
Abstract
The World Health Organization has published a global priority list of antibiotic-resistant bacteria to guide research and development of new antibiotics. Every pathogen on this list requires R&D activity, but some are more attractive for private sector investments, as evidenced by the current antibacterial pipeline. A “pipeline coordinator” is a governmental/non-profit organization that closely tracks the antibacterial pipeline and actively supports R&D across all priority pathogens employing new financing tools.My notes
Similar books and articles
Reprioritizing Research Activity for the Post‐Antibiotic Era: Ethical, Legal, and Social Considerations.Spencer Phillips Hey & Aaron S. Kesselheim - 2017 - Hastings Center Report 47 (2):16-20.
Constraining the use of antibiotics: applying Scanlon's contractualism.Michael Millar - 2012 - Journal of Medical Ethics 38 (8):465-469.
The Dangers of Pipeline Thinking: How the School‐To‐Prison Pipeline Metaphor Squeezes Out Complexity.Ken McGrew - 2016 - Educational Theory 66 (3):341-367.
Do physicians' legal duties to patients conflict with public health values? The case of antibiotic overprescription.Carl H. Coleman - 2009 - Journal of Bioethical Inquiry 6 (2):181-185.
A Grant Framework as a Push Incentive to Stimulate Research and Development of New Antibiotics.Miloje Savic & Christine Årdal - 2018 - Journal of Law, Medicine and Ethics 46 (s1):9-24.
Should Antibiotics Be Controlled Medicines? Lessons from the Controlled Drug Regimen.Live Storehagen, Friha Aftab, Christine Årdal, Miloje Savic & John-Arne RØttingen - 2018 - Journal of Law, Medicine and Ethics 46 (s1):81-94.
Scientific misconduct from the perspective of research coordinators: a national survey.E. R. Pryor, B. Habermann & M. E. Broome - 2007 - Journal of Medical Ethics 33 (6):365-369.
Simulating Market Entry Rewards for Antibiotics Development.Christopher Okhravi, Simone Callegari, Steve McKeever, Carl Kronlid, Enrico Baraldi, Olof Lindahl & Francesco Ciabuschi - 2018 - Journal of Law, Medicine and Ethics 46 (s1):32-42.
Nudge, Nudge or Shove, Shove—The Right Way for Nudges to Increase the Supply of Donated Cadaver Organs.Kyle Powys Whyte, Evan Selinger, Arthur L. Caplan & Jathan Sadowski - 2012 - American Journal of Bioethics 12 (2):32-39.
Paper: Can antibiotic use be both just and sustainable… or only more or less so?Michael Millar - 2011 - Journal of Medical Ethics 37 (3):153-157.
Love in the Time of Antibiotic Resistance: How Altruism Might Be Our Best Hope.Dien Ho - 2017 - In Philosophical Issues in Pharmaceutics: Development, Dispensing, and Use. Springer.
Taxing Meat: Taking Responsibility for One’s Contribution to Antibiotic Resistance.Hannah Maslen, Julian Savulescu, Thomas Douglas, Patrick Birkl & Alberto Giubilini - 2017 - Journal of Agricultural and Environmental Ethics 30 (2):179-198.
What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J. Hoffman & Kevin Outterson - 2015 - Journal of Law, Medicine and Ethics 43 (2):363-368.
Disrupting the School-to-Prison Pipeline.Sofía Bahena, North Cooc, Rachel Currie-Rubin, Paul Kuttner & Monica Ng (eds.) - 2012 - Harvard Educational Review.
Compensation for Cures: Paying People to Participate in Challenge Studies.Jonathan Anomaly & Julian Savulescu - 2019 - Bioethics 33 (7):792-797.
Analytics
Added to PP
2018-07-20
Downloads
17 (#819,600)
6 months
8 (#292,366)
2018-07-20
Downloads
17 (#819,600)
6 months
8 (#292,366)
Historical graph of downloads
Citations of this work
A Grant Framework as a Push Incentive to Stimulate Research and Development of New Antibiotics.Miloje Savic & Christine Årdal - 2018 - Journal of Law, Medicine and Ethics 46 (s1):9-24.
Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives.Chantal M. Morel & Suzanne E. Edwards - 2018 - Journal of Law, Medicine and Ethics 46 (s1):75-80.
Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others.Esther Bettiol, Judith Hackett & Stephan Harbarth - 2018 - Journal of Law, Medicine and Ethics 46 (s1):5-8.
References found in this work
Simulating Market Entry Rewards for Antibiotics Development.Christopher Okhravi, Simone Callegari, Steve McKeever, Carl Kronlid, Enrico Baraldi, Olof Lindahl & Francesco Ciabuschi - 2018 - Journal of Law, Medicine and Ethics 46 (s1):32-42.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-4c2ch uwo